ProSci Incorporated

ProSci Incorporated is a privately-held biotechnology firm located in San Diego, California doing business for over 20 years. A leader in its field, ProSci’s priority is to provide the highest quality monoclonal, polyclonal, and recombinant antibody products and services in the industry. ProSci’s expertise in antibody development, production, and biological research is realized through customizable services, innovative products, competitive pricing, high-quality research tools, and unparalleled technical support. ProSci Incorporated specializes in the production of affinity-purified peptide-specific polyclonal antibodies to novel antigens in fields such as HIV. Many of the polyclonal research antibodies offered by ProSci are affinity-purified, which allows for the isolation of antibodies specific to the epitope of interest. In addition, ProSci offers a complete assortment of reagents for immunochemical assays, including cell line lysates, tissue lysates and peptides as controls for these antibodies. ProSci’s innovative research approach using genetically engineered yeast strain and glycoproteins to mimic the HIV-1 glycan coat and develop neutralizing antibodies against HIV-1 glycans has been awarded several Small Business Innovative Research (SBIR) grants by NIH. ProSci’s custom antibody services specialize in polyclonal, monoclonal, and recombinant rabbit monoclonal and recombinant llama single domain antibody development and production.